Efficacy of systemic Chemotherapy on high-risk stage II and III Mucnious colon cancer. CHEMUCCA study part I

Áreas de investigación:

• Sin categoría

Año:

2024

Tipo de publicación:

Artículo

Palabras clave:

Mucinous colon cancer, Systematic chemotherapy, Rectal cancer

Autores:

• Trinidad-Gutiérrez, Irene
• Vázquez-Borrego, Mari C.
• Aguilera-Fernández, Eva
• Velez-Castaño, Juan E.
• Muriel-López, Carlos E.
• Rodríguez-Ortíz, Lidia
• Gómez-Orellana, Antonio Manuel
• Bérchez-Moreno, Francisco
• Hervás-Martínez, César
• Romero-Ruiz, Antonio
• Arjona-Sánchez, Álvaro

Journal:

European Journal of Surgical Oncology

Volumen:

50

Mes:

November

ISSN:

1532-2157

BibTex:

@article{Chemuca_part1_2024, author = "Irene Trinidad-Guti{\'e}rrez and Mari C. V{\'a}zquez-Borrego and Eva Aguilera-Fern{\'a}ndez and Juan E. Velez-Casta{\~n}o and Carlos E. Muriel-L{\'o}pez and Lidia Rodr{\'i}guez-Ort{\'i}z and Antonio Manuel G{\'o}mez-Orellana and Francisco B{\'e}rchez-Moreno and C{\'e}sar Herv{\'a}s-Mart{\'i}nez and Antonio Romero-Ruiz and {\'A}lvaro Arjona-S{\'a}nchez", abstract = "Locally advanced colon cancer is a high-risk condition for tumour recurrence with poor survival. The current treatment is surgery followed by adjuvant chemotherapy based on fluoropyrimidines and oxaliplatin. This approach has improved the oncological outcomes on this population, however the mucinous condition has not been studied in depth and although the evidence is weak, it is thought to have a worse response to systemic chemotherapy. The CHEMUCCA study aims to answer this question.", awards = "JCR (2023): 3.5, Position: 31/290 (Q1), Category: SURGERY", comments = "JCR (2023): 3.5, Position: 31/290 (Q1), Category: SURGERY", doi = "10.1016/j.ejso.2024.108642", issn = "1532-2157", journal = "European Journal of Surgical Oncology", keywords = "Mucinous colon cancer, Systematic chemotherapy, Rectal cancer", month = "November", note = "JCR (2023): 3.5, Position: 31/290 (Q1), Category: SURGERY", title = "{E}fficacy of systemic {C}hemotherapy on high-risk stage {II} and {III} {M}ucnious colon cancer. {CHEMUCCA} study part {I}", url = "www.sciencedirect.com/science/article/pii/S0748798324006942?via%3Dihub", volume = "50", year = "2024", }

Nota:

JCR (2023): 3.5, Position: 31/290 (Q1), Category: SURGERY

Abstract:

Locally advanced colon cancer is a high-risk condition for tumour recurrence with poor survival. The current treatment is surgery followed by adjuvant chemotherapy based on fluoropyrimidines and oxaliplatin. This approach has improved the oncological outcomes on this population, however the mucinous condition has not been studied in depth and although the evidence is weak, it is thought to have a worse response to systemic chemotherapy. The CHEMUCCA study aims to answer this question.

Comentarios:

JCR (2023): 3.5, Position: 31/290 (Q1), Category: SURGERY